Combination vinblastine, prednisolone and toceranib phosphate for treatment of grade II and III mast cell tumours in dogs.

about

Combination vinblastine, prednisolone and toceranib phosphate for treatment of grade II and III mast cell tumours in dogs.

Item

http://www.wikidata.org/entity/Q54978288

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Combination vinblastine, predn ...... III mast cell tumours in dogs.

@en

Combination vinblastine, predn ...... III mast cell tumours in dogs.

@nl

type

Item

label

Combination vinblastine, predn ...... III mast cell tumours in dogs.

@en

Combination vinblastine, predn ...... III mast cell tumours in dogs.

@nl

prefLabel

Combination vinblastine, predn ...... III mast cell tumours in dogs.

@en

Combination vinblastine, predn ...... III mast cell tumours in dogs.

@nl

P1476

Combination vinblastine, predn ...... III mast cell tumours in dogs.

@en

P2093

Kathleen O'Connell

http://www.w3.org/2001/XMLSchema#string

Ken Wyatt

http://www.w3.org/2001/XMLSchema#string

Maurine Thomson

http://www.w3.org/2001/XMLSchema#string

P2860

c-Kit expression, angiogenesis, and grading in canine mast cell tumour: a unique model to study c-Kit driven human malignancies.

Multi-center, placebo-controlled, double-blind, randomized study of oral toceranib phosphate (SU11654), a receptor tyrosine kinase inhibitor, for the treatment of dogs with recurrent (either local or distant) mast cell tumor following surgical excis

Evaluation of the adverse event profile and pharmacodynamics of toceranib phosphate administered to dogs with solid tumors at doses below the maximum tolerated dose.

Pulse-Administered Toceranib Phosphate Plus Lomustine for Treatment of Unresectable Mast Cell Tumors in Dogs.

Aggressive local therapy combined with systemic chemotherapy provides long-term control in grade II stage 2 canine mast cell tumour: 21 cases (1999-2012).

Safety evaluation of combination vinblastine and toceranib phosphate (Palladia®) in dogs: a phase I dose-finding study.

Multicenter prospective trial of hypofractionated radiation treatment, toceranib, and prednisone for measurable canine mast cell tumors.

European consensus document on mast cell tumours in dogs and cats.

A retrospective review of treatment and response of high-risk mast cell tumours in dogs.

Response evaluation criteria for solid tumours in dogs (v1.0): a Veterinary Cooperative Oncology Group (VCOG) consensus document.

P31

scholarly article

P356

10.1002/VMS3.106

http://www.w3.org/2001/XMLSchema#string

P50

Jaime A Olsen

P577

2018-05-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29797551

http://www.w3.org/2001/XMLSchema#string

P921

mast cells

P932

6090407

http://www.w3.org/2001/XMLSchema#string